# Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel

Study · id `cardio:ct-nct02925923` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02925923](<https://clinicaltrials.gov/study/NCT02925923>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02925923

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT02925923. Randomized; no masking; primary purpose treatment. Start 2016-11-01 (actual); primary completion 2018-01-30 (actual). Results posted on 2020-05-04.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Started: 2016-11-01 (actual) (ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Primary completion: 2018-01-30 (actual) (ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Completion: 2018-12-01 (actual) (ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Results first posted: 2020-05-04 (ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02925923, source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02925923-2020-05-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
- Condition: Acute Coronary Syndrome
- Condition: Angina, Unstable
- Intervention (Drug): Ticagrelor
- Intervention (Drug): Eptifibatide
- Intervention (Drug): Clopidogrel
- Lead sponsor: University of Alabama at Birmingham
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: University of Alabama at Birmingham (`cardio:org-university-of-alabama-at-birmingham`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial (`cardio:pubmed-31766977`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a1bab28b5c7927352b0b1ac042a1900ea4e825767e94382a7ce8a05f6507230a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
